These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 26781273)

  • 1. Inhibition of Galectin-3 Pathway Prevents Isoproterenol-Induced Left Ventricular Dysfunction and Fibrosis in Mice.
    Vergaro G; Prud'homme M; Fazal L; Merval R; Passino C; Emdin M; Samuel JL; Cohen Solal A; Delcayre C
    Hypertension; 2016 Mar; 67(3):606-12. PubMed ID: 26781273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic and pharmacological inhibition of galectin-3 prevents cardiac remodeling by interfering with myocardial fibrogenesis.
    Yu L; Ruifrok WP; Meissner M; Bos EM; van Goor H; Sanjabi B; van der Harst P; Pitt B; Goldstein IJ; Koerts JA; van Veldhuisen DJ; Bank RA; van Gilst WH; Silljé HH; de Boer RA
    Circ Heart Fail; 2013 Jan; 6(1):107-17. PubMed ID: 23230309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galectin-3 blockade inhibits cardiac inflammation and fibrosis in experimental hyperaldosteronism and hypertension.
    Martínez-Martínez E; Calvier L; Fernández-Celis A; Rousseau E; Jurado-López R; Rossoni LV; Jaisser F; Zannad F; Rossignol P; Cachofeiro V; López-Andrés N
    Hypertension; 2015 Oct; 66(4):767-75. PubMed ID: 26238446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac-deleterious role of galectin-3 in chronic angiotensin II-induced hypertension.
    González GE; Rhaleb NE; D'Ambrosio MA; Nakagawa P; Liao TD; Peterson EL; Leung P; Dai X; Janic B; Liu YH; Yang XP; Carretero OA
    Am J Physiol Heart Circ Physiol; 2016 Nov; 311(5):H1287-H1296. PubMed ID: 27496875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galectin-3 Participates in Cardiovascular Remodeling Associated With Obesity.
    Martínez-Martínez E; López-Ándres N; Jurado-López R; Rousseau E; Bartolomé MV; Fernández-Celis A; Rossignol P; Islas F; Antequera A; Prieto S; Luaces M; Cachofeiro V
    Hypertension; 2015 Nov; 66(5):961-9. PubMed ID: 26351031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of galectin-3 inhibition on aldosterone-induced cardiac and renal injuries.
    Calvier L; Martinez-Martinez E; Miana M; Cachofeiro V; Rousseau E; Sádaba JR; Zannad F; Rossignol P; López-Andrés N
    JACC Heart Fail; 2015 Jan; 3(1):59-67. PubMed ID: 25458174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-acetyl-seryl-aspartyl-lysyl-proline prevents cardiac remodeling and dysfunction induced by galectin-3, a mammalian adhesion/growth-regulatory lectin.
    Liu YH; D'Ambrosio M; Liao TD; Peng H; Rhaleb NE; Sharma U; André S; Gabius HJ; Carretero OA
    Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H404-12. PubMed ID: 19098114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galectin-3 deficiency ameliorates fibrosis and remodeling in dilated cardiomyopathy mice with enhanced Mst1 signaling.
    Nguyen MN; Ziemann M; Kiriazis H; Su Y; Thomas Z; Lu Q; Donner DG; Zhao WB; Rafehi H; Sadoshima J; McMullen JR; El-Osta A; Du XJ
    Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H45-H60. PubMed ID: 30387702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aldosterone inhibits antifibrotic factors in mouse hypertensive heart.
    Azibani F; Benard L; Schlossarek S; Merval R; Tournoux F; Fazal L; Polidano E; Launay JM; Carrier L; Chatziantoniou C; Samuel JL; Delcayre C
    Hypertension; 2012 Jun; 59(6):1179-87. PubMed ID: 22547442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modified citrus pectin ameliorates myocardial fibrosis and inflammation via suppressing galectin-3 and TLR4/MyD88/NF-κB signaling pathway.
    Xu GR; Zhang C; Yang HX; Sun JH; Zhang Y; Yao TT; Li Y; Ruan L; An R; Li AY
    Biomed Pharmacother; 2020 Jun; 126():110071. PubMed ID: 32172066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulated galectin-3 is not a critical disease mediator of cardiomyopathy induced by β
    Nguyen MN; Su Y; Kiriazis H; Yang Y; Gao XM; McMullen JR; Dart AM; Du XJ
    Am J Physiol Heart Circ Physiol; 2018 Jun; 314(6):H1169-H1178. PubMed ID: 29424570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial Injury After Ischemia/Reperfusion Is Attenuated By Pharmacological Galectin-3 Inhibition.
    Ibarrola J; Matilla L; Martínez-Martínez E; Gueret A; Fernández-Celis A; Henry JP; Nicol L; Jaisser F; Mulder P; Ouvrard-Pascaud A; López-Andrés N
    Sci Rep; 2019 Jul; 9(1):9607. PubMed ID: 31270370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Galectin-3 mediates aldosterone-induced vascular fibrosis.
    Calvier L; Miana M; Reboul P; Cachofeiro V; Martinez-Martinez E; de Boer RA; Poirier F; Lacolley P; Zannad F; Rossignol P; López-Andrés N
    Arterioscler Thromb Vasc Biol; 2013 Jan; 33(1):67-75. PubMed ID: 23117656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mineralocorticoid receptor antagonists modulate galectin-3 and interleukin-33/ST2 signaling in left ventricular systolic dysfunction after acute myocardial infarction.
    Lax A; Sanchez-Mas J; Asensio-Lopez MC; Fernandez-Del Palacio MJ; Caballero L; Garrido IP; Pastor-Perez FJ; Januzzi JL; Pascual-Figal DA
    JACC Heart Fail; 2015 Jan; 3(1):50-58. PubMed ID: 25458175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gal-3 (Galectin-3) and K
    She G; Hou MC; Zhang Y; Zhang Y; Wang Y; Wang HF; Lai BC; Zhao WB; Du XJ; Deng XL
    Hypertension; 2020 Feb; 75(2):393-404. PubMed ID: 31838908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of catecholamine-induced cardiac fibrosis by an aldosterone antagonist.
    Bos R; Mougenot N; Findji L; Médiani O; Vanhoutte PM; Lechat P
    J Cardiovasc Pharmacol; 2005 Jan; 45(1):8-13. PubMed ID: 15613973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modified citrus pectin prevents isoproterenol-induced cardiac hypertrophy associated with p38 signalling and TLR4/JAK/STAT3 pathway.
    Li Y; Zhou WW; Sun JH; Yang HX; Xu GR; Zhang Y; Song QH; Zhang C; Liu WZ; Liu XC; Li AY
    Biomed Pharmacother; 2021 Nov; 143():112178. PubMed ID: 34649308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological inhibition of the mitochondrial NADPH oxidase 4/PKCα/Gal-3 pathway reduces left ventricular fibrosis following myocardial infarction.
    Asensio-Lopez MDC; Lax A; Fernandez Del Palacio MJ; Sassi Y; Hajjar RJ; Pascual-Figal DA
    Transl Res; 2018 Sep; 199():4-23. PubMed ID: 29753686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin type 2 receptor stimulation ameliorates left ventricular fibrosis and dysfunction via regulation of tissue inhibitor of matrix metalloproteinase 1/matrix metalloproteinase 9 axis and transforming growth factor β1 in the rat heart.
    Lauer D; Slavic S; Sommerfeld M; Thöne-Reineke C; Sharkovska Y; Hallberg A; Dahlöf B; Kintscher U; Unger T; Steckelings UM; Kaschina E
    Hypertension; 2014 Mar; 63(3):e60-7. PubMed ID: 24379181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galectin-3 mediates the pulmonary arterial hypertension-induced right ventricular remodeling through interacting with NADPH oxidase 4.
    He J; Li X; Luo H; Li T; Zhao L; Qi Q; Liu Y; Yu Z
    J Am Soc Hypertens; 2017 May; 11(5):275-289.e2. PubMed ID: 28431936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.